280 search results
- Current search:
- Endocrine & metabolic
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
UpdatedCochrane EvidencePublished 7 Jul 2017
Statins for children with inherited high blood cholesterol
Review question We reviewed the evidence for the effectiveness and safety of statins in children with inherited high blood cholesterol. Background Familial hypercholesterolemia is an inherited disease in which the blood cholesterol level is high. Vascular disease, i.e. furring up of the blood vessels, often occurs at an earlier age than usual, especially ... -
NewCochrane EvidencePublished 28 Jun 2017
Phototherapy for treating foot ulcers in people with diabetes
Review question Phototherapy is a pain-free method of treatment that uses light to treat various medical conditions. We reviewed the evidence about phototherapy for foot ulcers in people with diabetes. We wanted to find out whether phototherapy speeds up wound healing and improves patients' quality of life, and whether there are any side effects. Background Foot ... -
NewCochrane EvidencePublished 22 Jun 2017
Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years
Review question How effective are diet, physical activity and behavioural interventions in reducing the weight of overweight or obese children aged 6 to 11 years? Background Across the world more children are becoming overweight and obese. These children are more likely to suffer from health problems, both while as children and in later life. More ... -
NewCochrane EvidencePublished 22 Jun 2017
Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years
Review question How effective are diet, physical activity and behavioural interventions in reducing the weight of overweight or obese adolescents aged 12 to 17 years? Background Across the world, more adolescents are becoming overweight and obese. These adolescents are more likely to suffer from health problems in later life. More information is ... -
UpdatedCochrane EvidencePublished 21 Jun 2017
Anti-vascular endothelial growth factor (anti-VEGF) drugs for diabetic macular oedema
What is the aim of this review? The aim of this Cochrane Review was to find out which is the best type of anti-VEGF drug for diabetic macular oedema (DMO). Cochrane researchers collected and analysed all relevant studies to answer this question and found 24 studies. Key messages Anti-VEGF drugs given by injection into the eye improve vision in people ... -
NewCochrane EvidencePublished 14 Jun 2017
Topical antimicrobial agents (antibacterial products applied directly to wounds) for treating foot ulcers in people with diabetes
Review question We reviewed the evidence about whether or not antimicrobial agents (antibacterial products) can prevent or treat foot infections in people with diabetes when they are applied topically (directly to the affected area). We wanted to find out if antibacterial treatments could help both infected and uninfected wounds to heal, and prevent ... -
UpdatedCochrane EvidencePublished 11 Jun 2017
Methods for monitoring blood glucose in pregnant women with diabetes to improve outcomes
What is the issue? If a mother already has diabetes when she becomes pregnant, she and her baby are at a higher risk of various problems in pregnancy, labour, birth and later. During pregnancy, the mother will have her blood glucose levels (sometimes referred to as blood sugar levels) monitored so appropriate steps can be taken to control her blood ... -
NewCochrane EvidencePublished 8 Jun 2017
Glucose targets for preventing diabetic kidney disease and its progression
What is the issue? In many parts of the world, diabetes is the most common reason that people experience kidney failure and need treatment with a kidney transplant or dialysis. Disability (blindness, limb loss, kidney failure) due to diabetes is caused by high blood glucose (sugar) levels. An important question is whether extra treatment to control ... -
Cochrane EvidencePublished 12 May 2017
Intermediate hyperglycaemia as a predictor for the development of type 2 diabetes: prognostic factor exemplar review
Protocol: To assess whether intermediate hyperglycaemia is a predictor for the development of type 2 diabetes mellitus (T2DM). -
Cochrane EvidencePublished 10 May 2017
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus
Review question Are the glucose-lowering medicines, DPP-4 inhibitors (e.g. linagliptin or vildagliptin) and GLP-1 analogues (e.g. exenatide or liraglutide) able to prevent or delay the development of type 2 diabetes and its associated complications in people at risk for the development of type 2 diabetes? Background DPP-4 inhibitors and GLP-1 analogues ...
